home / stock / rxst / rxst news


RXST News and Press, RxSight Inc. From 05/08/24

Stock Information

Company Name: RxSight Inc.
Stock Symbol: RXST
Market: NASDAQ
Website: rxsight.com

Menu

RXST RXST Quote RXST Short RXST News RXST Articles RXST Message Board
Get RXST Alerts

News, Short Squeeze, Breakout and More Instantly...

RXST - RxSight announces proposed offering of common stock

2024-05-08 16:57:21 ET More on RxSight RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript RxSight Non-GAAP EPS of -$0.13 be...

RXST - RxSight files automatic mixed shelf

2024-05-08 16:32:38 ET More on RxSight RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation Read the full article on Seeking Alpha For further details see: RxSight files autom...

RXST - RxSight, Inc. (RXST) Q1 2024 Earnings Call Transcript

2024-05-06 22:06:02 ET RxSight, Inc. (RXST) Q1 2024 Earnings Conference Call May 06, 2024 4:30 PM ET Company Participants Oliver Moravcevic – Vice President, Investor Relations Ron Kurtz – President and Chief Executive Officer Shelley Thunen –...

RXST - Buy Recommendation Issued On RXST By BTIG

2024-05-06 21:30:02 ET BTIG analyst issues BUY recommendation for RXST on May 6, 2024 08:04PM ET. The previous analyst recommendation was Buy. RXST was trading at $62.84 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst reco...

RXST - RxSight Non-GAAP EPS of -$0.12 beats by $0.07, revenue of $29.5M beats by $1.94M

2024-05-06 16:15:17 ET More on RxSight RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript RxSight Non-GAAP EPS of -$0.13 beats by $0.14, revenue of $28.6M beats by $0.74M RxSigh...

RXST - RxSight, Inc. Reports First Quarter 2024 Financial Results

ALISO VIEJO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended March 31,...

RXST - RXST Price Target Alert: $68.00. Issued by Stifel Nicolaus

2024-05-06 10:00:10 ET Thomas Stephan from Stifel Nicolaus issued a price target of $68.00 for RXST on 2024-05-06 08:42:00. The adjusted price target was set to $68.00. At the time of the announcement, RXST was trading at $61.68. The overall price target consensus is at ...

RXST - Expected US Company Earnings on Monday, May 6th, 2024

PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....

RXST - Notable earnings after Monday's close

2024-05-05 17:35:41 ET Major earnings expected after the bell on Monday include: Palantir Technologies ( PLTR ) Realty Income Corporation ( O ) Lucid Group ( LCID ) Simon Property Group ( SPG ) Vertex Pharmaceuticals Incorporated ( VRTX ) Re...

RXST - RxSight: Promising Technology, Uncertain Profitability - A Hold Recommendation

2024-05-01 06:06:07 ET Summary RxSight offers a revolutionary adjustable IOL technology with superior outcomes and reduced side effects compared to traditional IOLs. The company's "razor-and-blade" business model, with the LAL and LDD, provides precise post-surgical vision adjustm...

Previous 10 Next 10